Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 4 Pain, Postoperative 2 Vomiting 1 Urinary Incontinence, Stress 1 Urinary Incontinence 1 Urinary Bladder Neoplasms 1 Shoulder Pain 1 Psychomotor Agitation 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Neuroblastoma 1 Neoplasms 1 Myofibroma 1 Menstruation Disturbances 1 Lung Neoplasms 1 Liver Neoplasms 1 Laryngeal Neoplasms 1 Head and Neck Neoplasms 1 Gynecologic Oncology Patient 1 Endometrial Neoplasms 1 Cognitive Dysfunction 1 Anxiety Disorders 1 Advanced Breast Cancer 1

Interventions

Gemcitabine 79 Cisplatin 56 pembrolizumab 32 Paclitaxel 28 Carboplatin 24 Docetaxel 19 Radiotherapy 17 Mitomycin 16 Doxorubicin 15 atezolizumab 14 BCG Vaccine 14 Nivolumab 13 Cystectomy 13 Filgrastim 11 vinflunine 10 Methotrexate 10 Vinblastine 9 Fluorouracil 9 5-aminolevulinic acid hexyl ester 9 Sunitinib 7 Early Intervention, Educational 7 durvalumab 6 avelumab 6 Taxes 6 Methods 6 Cystoscopy 6 Albumin-Bound Paclitaxel 6 enfortumab vedotin 5 Trastuzumab 5 Surveys and Questionnaires 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Urinary Bladder Neoplasms × Population Groups × Clear all

NCT02676180 2023-12-08

DETECT I

University College, London

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡